Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...
EXCLUSIVE: Retta details the moment she was diagnosed with Type 2 diabetes
Retta reveals the first symptoms of her Type 2 diabetes. The actor shares the lifestyle changes she made and the glucose ...
Le Lézard3m
AHEAD Unveils Panel-Agnostic Automated AML Diagnosis Solution
AHEAD Medicine Corporation, a pioneering AI HealthTech company, is excited to announce a significant advancement in its flagship product, Cyto-Copilot. The new analysis module now supports AML versus ...
Le Lézard9m
Integrated DNA Technologies Unveils New Lymphoma Panel to Enhance Blood Cancer Research
Integrated DNA Technologies, a global leader in genomics solutions, proudly announces the expansion of its Archertm next-generation sequencing (NGS) assay solutions portfolio with the new Archer ...
ROSEN, A LEADING NATIONAL FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DXCM
New York, New York-- (Newsfile Corp. - September 22, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, ...
Medscape13h
Insulin Therapy De-Escalation to Fixed-Ratio Combo Safe
The results were further supported by data from continuous glucose monitoring (CGM; Freestyle Libre Pro iQ), which was used by approximately 80% of patients in the study and reported in a separate ...